Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/03/2856946/0/en/BioCorRx-Pharmaceuticals-Inc-Awarded-New-Patent-for-Novel-Compound-to-Treat-Pain-Depression-and-Schizophrenia.html
https://www.globenewswire.com/news-release/2024/04/02/2855969/0/en/BioCorRx-Reports-Business-Update-for-2023.html
https://www.globenewswire.com//news-release/2024/02/28/2837155/0/en/BioCorRx-Pharmaceuticals-Inc-Awarded-NIDA-Grant-of-Approximately-11-million-Over-Three-Years-for-Research-on-BICX104-a-Naltrexone-Implant-in-Combination-with-Bupropion-for-the-Trea.html
https://www.globenewswire.com//news-release/2024/02/08/2826159/0/en/BioCorRx-Pharmaceuticals-Inc-Appoints-Neuroscientist-Dr-Kate-DeVarney-to-the-Board-of-Directors.html
https://www.globenewswire.com//news-release/2024/01/09/2806288/0/en/BioCorRx-Appoints-Renowned-Investment-and-Capital-Markets-Executive-Louis-Lucido-as-President.html
https://www.globenewswire.com//news-release/2023/11/14/2780399/0/en/BioCorRx-Reports-Business-Update-for-the-Third-Quarter-of-2023.html
https://www.globenewswire.com/news-release/2023/08/15/2725537/0/en/BioCorRx-Submits-Expanded-Access-Treatment-Protocol-to-FDA-for-BICX104-Implantable-Biodegradable-Naltrexone-Pellet-for-Treatment-of-Opioid-Use-Disorder.html
https://www.globenewswire.com/news-release/2023/08/14/2725060/0/en/BioCorRx-Reports-Business-Update-for-the-Second-Quarter-of-2023.html
https://www.globenewswire.com/news-release/2023/07/18/2706412/0/en/BioCorRx-Submits-Fast-Track-Application-to-FDA-for-BICX104-an-Implantable-Biodegradable-Naltrexone-Pellet-for-The-Treatment-of-Opioid-Use-Disorder.html
https://www.globenewswire.com/news-release/2023/05/16/2669960/0/en/BioCorRx-Provides-Business-Update-for-the-First-Quarter-of-2023.html